You're viewing a public preview of Esperion Therapeutics, Inc. Sign up free to access full investment history, financials, executives & more
Sign Up Free Log In

Esperion Therapeutics, Inc.

Active
3891 Ranchero Drive, Suite 150,  Ann Arbor,  Michigan (MI),  48108,  United States
Sector: Life Science Entity: Public (NASDAQ, ESPR) Founded: 2008
2008
Founded
Year established
2013
IPO Year
Public listing
2
Transactions
Sign up to view
1
M&A Activity
Sign up to view
About Esperion Therapeutics, Inc.
Esperion Therapeutics, Inc. is a United States–based biopharmaceutical company focused on the development and commercialization of therapies for cardiovascular disease. The company develops oral, non-statin lipid-lowering treatments intended to reduce low-density lipoprotein cholesterol (LDL-C) in patients at risk of atherosclerotic cardiovascular disease. Esperion conducts research, clinical development, regulatory, and commercialization activities related to prescription pharmaceutical products distributed in the United States and international markets through partnerships and licensing arrangements. Esperion Therapeutics was founded in 2008 and is headquartered in Ann Arbor, Michigan, United States.
Investors
Current Investors
Pfizer, Inc. ••••••••
Past Investors
•••••••• ••••••••
View Full Investor List
Sign up to see all current & past investors with deal dates and transaction details
Sign Up Free Log In
Investment Details
2 Transactions
Trans. IDInvestment DateExit DateInvestor(s)Deal Size (M)Seller(s)
Access 2 Transactions
Sign up to view the full investment history — dates, deal sizes, investors & sellers
Sign Up Free Log In
Esperion Therapeutics, Inc. M&A Activity
1 Acquisition
# Company Transaction Date Close Date Sector Country
View 1 M&A Acquisition
Sign up to explore the full acquisition & merger history
Sign Up Free Log In
Key Executives & Professionals
View Executives & Professionals
Sign up to access board members, senior management & key contacts
Sign Up Free Log In
Frequently Asked Questions
What does Esperion Therapeutics, Inc. do?
Esperion Therapeutics, Inc. is a United States–based biopharmaceutical company focused on the development and commercialization of therapies for cardiovascular disease. The company develops oral, non-statin lipid-lowering treatments intended to reduce low-density lipoprotein cholesterol (LDL-C) in
Where is Esperion Therapeutics, Inc. headquartered?
Esperion Therapeutics, Inc. is headquartered in Ann Arbor, Michigan (MI), United States.
When was Esperion Therapeutics, Inc. founded?
Esperion Therapeutics, Inc. was founded in 2008.
What sector is Esperion Therapeutics, Inc. in?
Esperion Therapeutics, Inc. operates in the Life Science sector.
Who are the investors in Esperion Therapeutics, Inc.?
Current investors in Esperion Therapeutics, Inc. include Pfizer, Inc.. Sign up to AcquityData to view full investor details, deal dates and transaction history.
How many M&A transactions has Esperion Therapeutics, Inc. been involved in?
Esperion Therapeutics, Inc. has 2 transactions tracked on AcquityData. Sign up to view full investment history including dates, deal sizes, investors and sellers.

Unlock the full Esperion Therapeutics, Inc. profile

Ownership & Investors M&A History Financials Key Executives Advisors & Lenders

Access Esperion Therapeutics, Inc.'s complete ownership history, M&A activity, investors, advisors and executives in one connected platform.

Start Free Trial